[go: up one dir, main page]

ES514993A0 - Un procedimiento para la preparacion de nuevos derivados de cefalosporina. - Google Patents

Un procedimiento para la preparacion de nuevos derivados de cefalosporina.

Info

Publication number
ES514993A0
ES514993A0 ES514993A ES514993A ES514993A0 ES 514993 A0 ES514993 A0 ES 514993A0 ES 514993 A ES514993 A ES 514993A ES 514993 A ES514993 A ES 514993A ES 514993 A0 ES514993 A0 ES 514993A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
cephalosporin derivatives
new cephalosporin
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES514993A
Other languages
English (en)
Other versions
ES8306158A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP55136449A external-priority patent/JPS5759894A/ja
Priority claimed from JP5523181A external-priority patent/JPS57169489A/ja
Priority claimed from JP8911681A external-priority patent/JPS57206687A/ja
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of ES514993A0 publication Critical patent/ES514993A0/es
Publication of ES8306158A1 publication Critical patent/ES8306158A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES514993A 1980-09-30 1982-08-13 Un procedimiento para la preparacion de nuevos derivados de cefalosporina. Expired ES8306158A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP55136449A JPS5759894A (en) 1980-09-30 1980-09-30 Cephalosporin for oral administration
JP5523181A JPS57169489A (en) 1981-04-13 1981-04-13 Cephalosporin derivative and its preparation
JP8911681A JPS57206687A (en) 1981-06-10 1981-06-10 Cephalosporin derivative and its preparation

Publications (2)

Publication Number Publication Date
ES514993A0 true ES514993A0 (es) 1983-05-01
ES8306158A1 ES8306158A1 (es) 1983-05-01

Family

ID=27295533

Family Applications (4)

Application Number Title Priority Date Filing Date
ES505923A Expired ES8302002A1 (es) 1980-09-30 1981-09-30 Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
ES514995A Expired ES8306759A1 (es) 1980-09-30 1982-08-13 Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
ES514994A Granted ES514994A0 (es) 1980-09-30 1982-08-13 Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
ES514993A Expired ES8306158A1 (es) 1980-09-30 1982-08-13 Un procedimiento para la preparacion de nuevos derivados de cefalosporina.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES505923A Expired ES8302002A1 (es) 1980-09-30 1981-09-30 Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
ES514995A Expired ES8306759A1 (es) 1980-09-30 1982-08-13 Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
ES514994A Granted ES514994A0 (es) 1980-09-30 1982-08-13 Un procedimiento para la preparacion de nuevos derivados de cefalosporina.

Country Status (11)

Country Link
US (2) US4486425A (es)
EP (1) EP0049118B1 (es)
KR (1) KR870000848B1 (es)
AU (1) AU547984B2 (es)
CA (1) CA1171404A (es)
DE (1) DE3174472D1 (es)
ES (4) ES8302002A1 (es)
FI (1) FI73440C (es)
IE (1) IE53177B1 (es)
NL (1) NL930098I2 (es)
PH (1) PH18740A (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458772B1 (en) 1909-10-07 2002-10-01 Medivir Ab Prodrugs
US5223496A (en) * 1987-11-10 1993-06-29 The Upjohn Company Cephalosporin antibiotics
JPH01230547A (ja) * 1988-01-14 1989-09-14 Takeda Chem Ind Ltd ３−オキソ酪酸第三ブチルの製造法及びその用途
DE3804841A1 (de) * 1988-02-17 1989-08-31 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
GB8809534D0 (en) * 1988-04-22 1988-05-25 Beecham Group Plc Novel compounds
DE3901405A1 (de) * 1989-01-19 1990-07-26 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
DE3919259A1 (de) * 1989-06-13 1990-12-20 Hoechst Ag Kristalline cephem-saeureadditionssalze und verfahren zu ihrer herstellung
YU48484B (sh) * 1991-05-24 1998-09-18 Hoechst Aktiengesellschaft Kristalne kiselinske adicione soli diastereomerno čistih 1-(2,2-dimetilpropioniloksi)-etilestara 3-cefem-4-karbonske kiseline
EP0531875B1 (de) * 1991-09-07 2004-03-24 Aventis Pharma Deutschland GmbH Diastereomer des 3-Cephem-4-carbonsäure-1-(-isopropoxycarbonyloxy)ethylesters und Verfahren zu dessen Herstellung
TW212181B (es) * 1992-02-14 1993-09-01 Hoechst Ag
DE59308295D1 (de) * 1992-05-21 1998-04-30 Hoechst Ag Verfahren zur Spaltung von Cephalosporin Prodrugestern zu 7-Amino-3-methoxymethylceph-3-em-4-carbonsäure
LT3870B (en) 1993-11-30 1996-04-25 Hoechst Ag Diastereomers of 3-cefem-4-carboxylic acid 1-(isopropoxy-carbonyloxy)ethyl ester, process for preparingthereof, antibacteric preparations based on same and process for preparation thereof
US5929086A (en) 1996-05-10 1999-07-27 Pharmacia & Upjohn Company Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
AT413383B (de) * 1998-01-09 2006-02-15 Sandoz Ag Verfahren zur isolierung eines diastereoisomerengemisches von cefpodoxim proxetil
AT408226B (de) 1999-05-05 2001-09-25 Biochemie Gmbh Kristalliner 7-(2-(2-formylaminothiazol-4-yl)-2
IN191496B (es) 1999-07-30 2003-12-06 Ranbaxy Lab Ltd
KR100342944B1 (ko) * 1999-11-08 2002-07-02 민경윤 고순도 세프포독심 프록세틸의 제조방법
US7045618B2 (en) * 2001-02-27 2006-05-16 Ranbaxy Laboratories Limited Cefpodixime proxetil
ES2248521T3 (es) * 2001-02-27 2006-03-16 Ranbaxy Laboratories, Ltd. Composicion farmaceutica oral de cefpodoxima proxetilo.
CA2477088A1 (en) 2002-02-22 2003-10-02 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US20060009639A1 (en) * 2002-11-22 2006-01-12 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of cefpodoxime proxetil
US20060293296A1 (en) * 2002-12-20 2006-12-28 Gharpure Milind M Process for the preparation of cefpodoxime procetil
GB0301938D0 (en) * 2003-01-28 2003-02-26 Biochemie Gmbh Organic compounds
US20040242863A1 (en) * 2003-05-27 2004-12-02 Carenini Alessandro Riccardo Preparation of cefalosporins intermediates and conversion of said intermediates into active compound precursors
WO2010097675A1 (en) 2009-02-27 2010-09-02 Dhanuka Laboratories Ltd. An improved preparation process for cefpodoxime proxetil
TR201002878A2 (tr) 2010-04-13 2011-10-21 Bi̇lgi̇ç Mahmut Sefpodoksim proksetil içeren farmasötik bileşimler.
EP2575777A1 (en) 2010-06-03 2013-04-10 Mahmut Bilgic Formulation comprising cefpodoxime proxetil and clavulanic acid
EP2575811B1 (en) 2010-06-03 2020-08-12 Mahmut Bilgic Pharmaceutical formulation comprising cefpodoxime proxetil and clavulanic acid
TR201007107A1 (tr) 2010-08-25 2012-03-21 B�Lg�� Mahmut Tat düzenleyici ajan içeren sefpodoksim proksetil formülasyonları.
TR201007106A1 (tr) 2010-08-25 2012-03-21 Bi̇lgi̇ç Mahmut Sefpodoksim proksetil formülasyonları.
TR201009168A2 (tr) 2010-11-05 2012-05-21 Bi̇lgi̇ç Mahmut Suda dağılan sefpodoksim proksetil formülasyonları.
EP2520578A1 (en) 2011-05-06 2012-11-07 Lupin Limited Process for purification of cephalosporins
EP2758407A1 (en) 2011-09-20 2014-07-30 Dhanuka Laboratories Ltd. An improved process for cefpodoxime acid
EP2833872A1 (en) 2012-04-04 2015-02-11 Mahmut Bilgic Tablet formulations comprising cefpodoxime proxetil and clavulanic acid
WO2014123500A1 (en) 2013-02-11 2014-08-14 Bilgiç Mahmut Pharmaceutical formulations comprising cefpodoxime proxetil and clavulanic acid

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024137A (en) * 1971-05-14 1977-05-17 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins
GB1425933A (en) * 1972-03-13 1976-02-25 Astra Laekemedel Ab Cephalosporins
JPS5119765A (en) * 1974-08-09 1976-02-17 Takeda Chemical Industries Ltd Aminochiazoorujudotaino seizoho
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DE2715385A1 (de) * 1976-04-14 1977-11-10 Takeda Chemical Industries Ltd Cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
JPS53103493A (en) * 1977-02-18 1978-09-08 Takeda Chem Ind Ltd Cephalosporin derivatives and process for their preparation
DE2714880A1 (de) 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
US4409215A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical Co., Ltd. 7-Acylamino-3-substituted cephalosporanic acid derivatives and processes for the preparation thereof
FR2476087A1 (fr) * 1980-02-18 1981-08-21 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
ES8306159A1 (es) 1983-05-01
US4486425A (en) 1984-12-04
EP0049118B1 (en) 1986-04-23
ES505923A0 (es) 1982-12-16
AU7578181A (en) 1982-04-08
ES514995A0 (es) 1983-06-01
EP0049118A3 (en) 1983-01-19
ES8302002A1 (es) 1982-12-16
KR830007685A (ko) 1983-11-04
IE812273L (en) 1982-03-30
KR870000848B1 (ko) 1987-04-25
CA1171404A (en) 1984-07-24
PH18740A (en) 1985-09-16
IE53177B1 (en) 1988-08-17
US4716158A (en) 1987-12-29
AU547984B2 (en) 1985-11-14
DE3174472D1 (en) 1986-05-28
NL930098I2 (nl) 1995-02-01
FI73440B (fi) 1987-06-30
FI813038L (fi) 1982-03-31
NL930098I1 (nl) 1993-10-01
EP0049118A2 (en) 1982-04-07
ES8306158A1 (es) 1983-05-01
ES8306759A1 (es) 1983-06-01
ES514994A0 (es) 1983-05-01
FI73440C (fi) 1987-10-09

Similar Documents

Publication Publication Date Title
ES505923A0 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
ES506661A0 (es) Un procedimiento para la preparacion de nuevos derivados de la sacarosa industrialmente utiles.
ES508286A0 (es) Un procedimiento para la preparacion de derivados de imidazolil-propanol.
ES518225A0 (es) Un procedimiento para la preparacion de nuevos derivados de oxabicicloalcano.
ES507298A0 (es) Un procedimiento para la preparacion de derivados de 2-feniletanolamina.
ES521635A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
ES524446A0 (es) Un procedimiento para la preparacion de nuevos derivados.
ES527661A0 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
ES522678A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina.
ES519057A0 (es) Un procedimiento para la preparacion de derivados de caprolactama.
ES505922A0 (es) Un procedimiento para la preparacion de nuevos derivados de cefalospirina.
ES516825A0 (es) Un procedimiento para la preparacion de nuevos derivados de 3-amino-pregn-5-eno.
ES515548A0 (es) Un procedimiento para la preparacion de un derivado de cefalosporina.
ES520224A0 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
ES510067A0 (es) Un procedimiento para la preparacion de nuevos derivados de benzoilurea.
ES524317A0 (es) Un procedimiento para la preparacion de nuevos derivados de tienopirimidina.
ES504790A0 (es) Un procedimiento para la preparacion de derivados de enantolactama.
ES518975A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-piperazino primidina.
ES501339A0 (es) Un procedimiento para la preparacion de derivados de 9-carbamoil-9-aminoalquilfluoreno.
ES504793A0 (es) Un procedimiento para la preparacion de nuevos derivados de caprilolactama.
ES506142A0 (es) Un procedimiento para la preparacion de nuevos acilderivadosde cefalosporina
ES507482A0 (es) Un procedimiento para la preparacion de nuevos derivados de acilaminoquimazolina.
ES505920A0 (es) Un procedimiento para la preparacion de derivados de isonicotinanilida.
ES504577A0 (es) Un procedimiento para la preparacion de derivados de piridazinona.
ES503338A0 (es) Un procedimiento para la preparacion de derivados de bis-hidroxibencilo.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20030224